Zejing Pharmaceuticals: Injection ZGGS18 and Injection ZG005 in combination with chemotherapy have obtained approval for clinical trials of the drug.

Zejing Pharmaceuticals announced that the company recently received the "Drug Clinical Trial Approval Notification" approved and issued by the National Medical Products Administration. The clinical trial of ZGGS18 for injection, ZG005 for injection, and chemotherapy combination therapy for advanced solid tumors has been approved.